Gemma Pattison
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Gemma Pattison has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Kathryn Hird
School of Medicine, University of Notre Dame Australia, Fremantle, Australia
2 shared publications - Nika Mohannak
School of Medicine, The University of Notre Dame, Fremantle, Western Australia 6160, Australia
2 shared publications - Bronwyn Radich
Department of Speech Pathology, Royal Perth Hospital, Perth, Western Australia, Australia
1 shared publication Erin Godecke
School of Medicine and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia
1 shared publicationFrank Mastaglia
The Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Western Australia, Australia
1 shared publicationMerrilee Needham
School of Medicine, The University of Notre Dame, Fremantle, Western Australia 6160, Australia; Department of Neurology, Fiona Stanley Hospital, Murdoch, Western Australia, Australia; The Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Western Australia, Australia
1 shared publication
Latest Publications
- 1 April 2020
- Published by Elsevier in Neuromuscular Disorders
- Vol. 30 (4) , 294-300
Exploring the efficacy of the expiratory muscle strength trainer to improve swallowing in inclusion body myositis: A pilot study
- 1 April 2020
- Published by Elsevier in Neuromuscular Disorders
- Vol. 30 (4) , 294-300
Exploring the efficacy of the expiratory muscle strength trainer to improve swallowing in inclusion body myositis: A pilot study
- Open Access
- 1 December 2019
- Published by Taylor & Francis in International Journal of General Medicine
- Vol. ume 12, 465-474
Dysphagia in Patients with Sporadic Inclusion Body Myositis: Management Challenges
Dysphagia in inclusion body myositis (IBM) is common and associated with increased mortality and morbidity due to aspiration pneumonia, malnutrition and dehydration. There is currently no consensus on treatment of dysphagia in IBM and outcomes are variable depending on timing of intervention, patient preference and available expertise. There is a paucity of research exploring the pathophysiology of dysphagia in IBM and appropriate investigations. Increased knowledge of the aetiopathogenesis is likely to change the approach to treatment as well as improve the quality of life for patients. This review explores the epidemiology and pathophysiology of dysphagia in IBM and the currently available treatment strategies.
- 1 December 2019
- Published by Taylor & Francis in International Journal of General Medicine
- Vol. ume 12, 465-474
Open AccessDysphagia in Patients with Sporadic Inclusion Body Myositis: Management Challenges
Dysphagia in inclusion body myositis (IBM) is common and associated with increased mortality and morbidity due to aspiration pneumonia, malnutrition and dehydration. There is currently no consensus on treatment of dysphagia in IBM and outcomes are variable depending on timing of intervention, patient preference and available expertise. There is a paucity of research exploring the pathophysiology of dysphagia in IBM and appropriate investigations. Increased knowledge of the aetiopathogenesis is likely to change the approach to treatment as well as improve the quality of life for patients. This review explores the epidemiology and pathophysiology of dysphagia in IBM and the currently available treatment strategies.